266 related articles for article (PubMed ID: 28928464)
1. GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.
Zeitvogel J; Jokmin N; Rieker S; Klug I; Brandenberger C; Werfel T
Sci Rep; 2017 Sep; 7(1):11847. PubMed ID: 28928464
[TBL] [Abstract][Full Text] [Related]
2. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.
Pellerin L; Henry J; Hsu CY; Balica S; Jean-Decoster C; Méchin MC; Hansmann B; Rodriguez E; Weindinger S; Schmitt AM; Serre G; Paul C; Simon M
J Allergy Clin Immunol; 2013 Apr; 131(4):1094-102. PubMed ID: 23403047
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family.
Wu Z; Hansmann B; Meyer-Hoffert U; Gläser R; Schröder JM
PLoS One; 2009; 4(4):e5227. PubMed ID: 19384417
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
Zeng YP; Nguyen GH; Jin HZ
Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
[TBL] [Abstract][Full Text] [Related]
5. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression.
Otsuka A; Doi H; Egawa G; Maekawa A; Fujita T; Nakamizo S; Nakashima C; Nakajima S; Watanabe T; Miyachi Y; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2014 Jan; 133(1):139-46.e1-10. PubMed ID: 24055295
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation.
Pendaries V; Malaisse J; Pellerin L; Le Lamer M; Nachat R; Kezic S; Schmitt AM; Paul C; Poumay Y; Serre G; Simon M
J Invest Dermatol; 2014 Dec; 134(12):2938-2946. PubMed ID: 24940654
[TBL] [Abstract][Full Text] [Related]
7. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation.
Howell MD; Fairchild HR; Kim BE; Bin L; Boguniewicz M; Redzic JS; Hansen KC; Leung DY
J Invest Dermatol; 2008 Sep; 128(9):2248-58. PubMed ID: 18385759
[TBL] [Abstract][Full Text] [Related]
8. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.
Naeem AS; Tommasi C; Cole C; Brown SJ; Zhu Y; Way B; Willis Owen SA; Moffatt M; Cookson WO; Harper JI; Di WL; Brown SJ; Reinheckel T; O'Shaughnessy RF
J Allergy Clin Immunol; 2017 Apr; 139(4):1228-1241. PubMed ID: 27913303
[TBL] [Abstract][Full Text] [Related]
9. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema.
Elias MS; Long HA; Newman CF; Wilson PA; West A; McGill PJ; Wu KC; Donaldson MJ; Reynolds NJ
J Allergy Clin Immunol; 2017 Nov; 140(5):1299-1309. PubMed ID: 28479159
[TBL] [Abstract][Full Text] [Related]
11. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models.
Cornelissen C; Marquardt Y; Czaja K; Wenzel J; Frank J; Lüscher-Firzlaff J; Lüscher B; Baron JM
J Allergy Clin Immunol; 2012 Feb; 129(2):426-33, 433.e1-8. PubMed ID: 22177328
[TBL] [Abstract][Full Text] [Related]
12. Update on canine filaggrin: a review.
Combarros D; Cadiergues MC; Simon M
Vet Q; 2020 Dec; 40(1):162-168. PubMed ID: 32308144
[TBL] [Abstract][Full Text] [Related]
13. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
Lee J; Song KM; Jung CH
Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
[TBL] [Abstract][Full Text] [Related]
14. Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunction.
Hansmann B; Ahrens K; Wu Z; Proksch E; Meyer-Hoffert U; Schröder JM
Exp Dermatol; 2012 Apr; 21(4):271-6. PubMed ID: 22417302
[TBL] [Abstract][Full Text] [Related]
15. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.
Gutowska-Owsiak D; Schaupp AL; Salimi M; Selvakumar TA; McPherson T; Taylor S; Ogg GS
Exp Dermatol; 2012 Feb; 21(2):104-10. PubMed ID: 22229441
[TBL] [Abstract][Full Text] [Related]
16. Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis.
Cole C; Kroboth K; Schurch NJ; Sandilands A; Sherstnev A; O'Regan GM; Watson RM; McLean WH; Barton GJ; Irvine AD; Brown SJ
J Allergy Clin Immunol; 2014 Jul; 134(1):82-91. PubMed ID: 24880632
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of S100 fused-type proteins in an atopic dermatitis skin model.
Makino T; Mizawa M; Takemoto K; Yamamoto S; Shimizu T
Exp Dermatol; 2023 Dec; 32(12):2160-2165. PubMed ID: 36995036
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.
Tsuji G; Hashimoto-Hachiya A; Kiyomatsu-Oda M; Takemura M; Ohno F; Ito T; Morino-Koga S; Mitoma C; Nakahara T; Uchi H; Furue M
Cell Death Dis; 2017 Jul; 8(7):e2931. PubMed ID: 28703805
[TBL] [Abstract][Full Text] [Related]
19. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
[TBL] [Abstract][Full Text] [Related]
20. Concentration of filaggrin monomers, its metabolites and corneocyte surface texture in individuals with a history of atopic dermatitis and controls.
Engebretsen KA; Bandier J; Kezic S; Riethmüller C; Heegaard NHH; Carlsen BC; Linneberg A; Johansen JD; Thyssen JP
J Eur Acad Dermatol Venereol; 2018 May; 32(5):796-804. PubMed ID: 29360238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
